extracellular flux (XF) analysis has become a mainstream method for measuring mitochondrial function in cells and tissues. although this technique is commonly used to measure bioenergetics in intact cells, we outline here a detailed XF protocol for measuring respiration in permeabilized cells. cells are permeabilized using saponin (sap), digitonin (DIG) or recombinant perfringolysin o (rpFo) (XF-plasma membrane permeabilizer (pMp) reagent), and they are provided with specific substrates to measure complex I-or complex II-mediated respiratory activity, complex III+IV respiratory activity or complex IV activity. Medium-and long-chain acylcarnitines or glutamine may also be provided for measuring fatty acid (Fa) oxidation or glutamine oxidation, respectively. this protocol uses a minimal number of cells compared with other protocols and does not require isolation of mitochondria. the results are highly reproducible, and mitochondria remain well coupled. collectively, this protocol provides comprehensive and detailed information regarding mitochondrial activity and efficiency, and, after preparative steps, it takes 6-8 h to complete.
IntroDuctIon
Metabolism comprises the crucial, life-sustaining chemical reactions occurring within cells and tissues. Mitochondria, in particular, are critical hubs for such biochemical transformations. Although best known for their capacity to produce energy through oxidative phosphorylation, they are also important for the synthesis of biomolecules and for regulating calcium homeostasis, cell survival decisions and redox signaling. Not surprisingly, these roles are highly integrated, such that perturbation in the machinery responsible for energy production, for example, could have substantial effects on related processes such as cataplerosis or apoptosis. Therefore, the ability to identify and quantify changes in specific components that constitute mitochondrial function is increasingly important for understanding the relationships between bioenergetics and changes in cell phenotype.
Development of the protocol
Measurements of mitochondrial function became common nearly half a century ago through the work of Chance and Williams 1, 2 . Their methods to isolate intact and active mitochondrial preparations (derived from modifications of methods from Schneider 3 , and Lardy and Wellman 4 ) paved the way for seminal discoveries in mitochondrial biology, including Peter Mitchell's chemiosmotic theory of oxidative phosphorylation 5 and the elucidation of the tricarboxylic acid (TCA) cycle 6 . As such, the measurement of mitochondrial function continues to be widely used to identify mechanistic bases of disease and for understanding the modes of toxicity of environmental factors and the mechanisms of drug action.
The specific aspects of mitochondrial biology that can be revealed in the purified organelle include assessment of respiratory activity, efficiency and capacity [7] [8] [9] ; reactive oxygen species (ROS) generation 10, 11 ; mitochondrial permeability transition [12] [13] [14] [15] ; protein import into the mitochondrion 16, 17 ; and the mitochondrial proteome [18] [19] [20] . Although assays using isolated mitochondria have bestowed remarkable knowledge of how disease affects each of these endpoints, this approach has several limitations. First, these methods require relatively large quantities of cells or tissues 21 , and standard techniques, e.g., differential centrifugation, commonly retrieve a low fraction of the total mitochondrial content. In tissues such as muscle, this latter shortcoming has been suggested to lead to bias owing to selective representation of the mitochondrial pool [22] [23] [24] . Second, the isolation process could decrease mitochondrial integrity 25 , with such damage possibly being more evident in mitochondria isolated from injured tissues 22 . Third, mitochondria isolated from cells and tissues are essentially stripped from their intracellular locales. This has been shown to result in changes in mitochondrial morphology, sensitization to mitochondrial permeability transition, alterations in mitochondrial respiration and increased ROS production 24, 25 . Hence, methods of measuring mitochondria in their unperturbed environment are probably more useful for identifying veritable changes in mitochondrial function due to disease conditions and interventions.
XF analysis has become a mainstream, high-throughput means to measure bioenergetic function in cells and tissues. This technique has overcome the limitations of classic oxygen electrodes, and it allows for the measurement of mitochondrial energetics in up to 24 or 96 samples (in XF24 or XF96 analyzers, respectively) at one time in intact, adherent cells 26, 27 . Data acquired via this technique can confer knowledge of changes in oxygen consumption owing to ATP turnover, proton leak and maximal respiratory capacity 9, [28] [29] [30] [31] [32] [33] [34] ; however, in intact cell and tissue 35 measurements, the ability to identify site-specific changes such as those due to damage to components of the respiratory chain or anaplerotic enzymes is diminished. Whereas isolated mitochondria allow for such measurements, they have the aforementioned limitations of the need for large amounts of starting material and of relatively poor yield; further limitations include deleterious changes to the mitochondrial architecture and function and selection bias. To bridge the gap between intact cell bioenergetic measurements and
Comprehensive measurement of respiratory activity in permeabilized cells using extracellular flux analysis isolated mitochondria experiments, a comprehensive XF assay to measure respiration in permeabilized cells has been developed. This assay, or modifications thereof, has been used to understand the effects of mitochondrial fission on cellular bioenergetics 36 , to identify novel metabolic actions of thiazolidinediones 37 and to understand the effects of drugs on mitochondrial toxicity in neurons 38 . The permeabilizers used in this assay have also been shown to work in other platforms, such as in suspended cells using an oxygen electrode 39, 40 .
The fundamental principles underlying the permeabilized cell methodology have been outlined elsewhere [40] [41] [42] [43] , with the following major improvements in this protocol: the application of the permeabilized cell methodology in the high-throughput XF24/96 system; a more thorough interrogation of electron transport chain (ETC) components, FA oxidation and anaplerotic metabolism; and the ability to select from a variety of permeabilizing agents, the properties of which may differ slightly. Briefly, the treatment of cells with compounds that form complexes with cholesterol, which is abundant in the plasma membrane and much lower in organelles such as mitochondria, results in selective plasmalemma permeabilization. In this protocol, we outline the use of three different permeabilizing agents: SAP, DIG and rPFO (XF-PMP reagent). Proper treatment with these agents causes the loss of plasma membrane integrity, resulting in the leakage of cytosolic solutes from the cell, with little to no effect on mitochondrial membranes. The addition of select oxidizable substrates, e.g., TCA cycle intermediates, acylcarnitines and amino acids, as well as ADP, uncouplers and inhibitors of respiratory complexes or membrane translocators, allows for a comprehensive interrogation of mitochondrial function.
In permeabilized cells, the architecture of organelles such as the endoplasmic reticulum and mitochondria, as well as the cytoskeleton, remains largely intact 44 . Whereas isolated mitochondria assume the globular or fragmented morphology, mitochondria in permeabilized cells retain their vermiform appearance and tubular network 25 . This is especially important because several studies show structure-function relationships in mitochondria that relate largely to fission and fusion activities and mitochondrial architecture [45] [46] [47] [48] . In addition, measuring the respiratory activity in permeabilized cells by using XF analysis allows for coordinated experiments to be designed in intact cells and in permeabilized cells. This could greatly increase the resolution for pinpointing consequential sites of mitochondrial damage and allow for a more complete understanding of the impact of site-specific changes in the context of intact cell bioenergetics and phenotype. By using the XF24 analyzer, these measurements use as few as 20,000 cells per well, which, compared with isolated mitochondria experiments using Clark-type electrodes, decreases the cell number requirement by up to 10,000-fold (optimal yield and quality of isolated mitochondria requires 2-200 × 10 6 cells or more 21, 38 ). The XF96 platform requires even lower cell numbers, as shown previously 37 .
Applications of the method
This method may be applied to most cells that adhere to polystyrene XF tissue culture microplates and should be applicable to the wide range of cells that have been tested in intact XF assays (see list at http://www.seahorsebio.com/learning/cell-line.php). To date, it has been shown to work in vascular smooth muscle cells, C2C12 cells, differentiated C2C12 myotubes, human skeletal muscle myotubes, neonatal rat cardiomyocytes, H9C2 cardiomyocytes, differentiated H9C2 cardiomyocytes, HEK 293a cells, HepG2 cells, RAW 264.7 macrophages L6 cells, rat cortical neurons and brown adipocyte precursors [36] [37] [38] . This method has the potential to be modified for use in measuring activity in tissue slices and muscle fibers 41 . With regard to application, this method should aid in understanding how conditions related to diabetes, neurodegeneration and cardiovascular disease affect mitochondrial function and bioenergetics. It is envisaged that this technique may also help describe the unique metabolic phenotypes of cancer cells and stem cells, and it could be useful in elucidating how metabolism integrates with and regulates cell differentiation and phenotype. In addition, this methodology may be useful for diagnosing systemic mitochondrial disease by using cells isolated from patients 40, 49 .
The application of this method allows for interrogation and measurement of the following in permeabilized cells ( Fig. 1): Complex I-mediated respiratory activity. Providing pyruvate or glutamate activates dehydrogenases, which reduce nicotinamide adenine dinucleotide (NAD + ) to NADH. NADH then feeds electrons into complex I (NADH-ubiquinone oxidoreductase) that transfer through the Q cycle to complex III, cytochrome c and finally to complex IV, which reduces O 2 to H 2 O. It should be noted that giving glutamate or pyruvate alone may result in much lower oxygen consumption rates (OCRs; e.g., ref. 50) than when combined with malate. In the absence of malate, the accumulation of acetyl CoA could inhibit pyruvate dehydrogenase (PDH) via feedback inhibition; therefore, the addition of small amounts of malate allows for oxaloacetate production and condensation with acetyl CoA, allowing normal PDH flux. In addition, pyruvate or glutamate given alone may result in the loss of some TCA cycle intermediates, e.g., through the dicarboxylate carrier.
In higher organisms, malate by itself will not support high rates of respiration in isolated mitochondria or in permeabilized cells and tissues. Oxaloacetate formed from malate cannot be metabolized further without a source of acetyl CoA (i.e., pyruvate), or in the case of added glutamate it can be metabolized to oxoglutarate, similarly to metabolism with acetyl CoA and citrate synthase. In addition, TCA cycle intermediates are depleted in the presence of malate alone: mitochondrial citrate and oxoglutarate can be depleted by antiport with malate through tricarboxylate and oxoglutarate carrier exchanges, respectively. Similarly, succinate is lost through the dicarboxylate carrier. It should be noted that complex II is generally not involved in respiration when complex I substrates are given. This is primarily owing to the fact that high malate concentrations both increase oxaloacetate and equilibrate with fumarate, which inhibits succinate dehydrogenase (SDH) activity, and oxoglutarate and succinate are lost into the medium because of carrier exchange.
Complex II-mediated respiratory activity. Complex II (SDH) is a membrane-bound enzyme that is also part of the TCA cycle. The addition of succinate results in its transport into mitochondria through the dicarboxylate carrier. Succinate is then oxidized to fumarate, with concomitant reduction of flavin adenine dinucleotide (FAD) to FADH 2 , and electrons are delivered into the Q cycle; however, rotenone must be present to prevent reverse electron transfer to complex I (which results in ROS production) and to prevent the accumulation of oxaloacetate, which is a more potent inhibitor of SDH than malonate. In the presence of rotenone, complex I is inhibited and malate is extruded from mitochondria through the dicarboxylate carrier, thereby preventing oxaloacetate accumulation.
Oxygen consumption deriving from complex III and IV activities. Complex III (ubiquinol:cytochrome c oxidoreductase) is a central component of the respiratory chain, catalyzing the transfer of electrons from ubiquinol to oxidized cytochrome c. As in complex I, this electron transfer reaction is coupled to proton translocation 51 . In intact cells and tissues, electrons feeding into complex III are derived from the oxidation of mitochondrial substrates (e.g., pyruvate and FAs, leading to the formation of NADH and FADH 2 ), with electrons donated initially to complex I and the Q cycle. Thus, the use of such substrates makes the identification of specific sites of damage more difficult because of the multiple enzymes and electron transfer reactions involved.
In permeabilized cells, complex III+IV activity and integrity can be assessed by using durohydroquinone (duroquinol) 40, [52] [53] [54] [55] .
Duroquinol donates electrons directly to complex III, and the rate of its oxidation requires electron transport through complexes III and IV; hence, the use of this substrate allows for the assessment of differences in respiratory activity derived from these latter electron transfer reactions.
Complex IV activity. The final step in the ETC catalyzes the transfer of four electrons from reduced cytochrome c to O 2 , forming H 2 O, with the concomitant pumping of protons into the intermembrane space. Complex IV (cytochrome c oxidase) activity has classically been measured by spectroscopic techniques. However, the activity of complex IV may also be measured in permeabilized cells (and isolated mitochondria) by recording the OCR when nonphysiological electron-donating compounds such as tetramethyl-p-phenylene diamine (TMPD) are used 56 . Here, ascorbate is added as a reductant to regenerate TMPD from its oxidized form (Wurster's blue). TMPD donates electrons to cytochrome c, which then reduces complex IV. Complex IV then reduces O 2 , thus forming water. being the principal route by which they are oxidized as fuel. Cells and tissues typically derive oxidizable fat via transport across the plasma membrane. Once inside the cell, FAs are activated by esterification to CoA-SH, which is catalyzed by acyl-CoA synthetases. However, for transport into the mitochondrion, the fatty acyl-CoA molecules typically must be esterified to carnitine, which is accomplished through the actions of carnitine palmitoyltransferase-I (CPT-I). A carnitine/acylcarnitine translocase then shuttles the acylcarnitine into the mitochondrion, where CPT-II then regenerates the acyl CoA molecule, which is the substrate for the FA oxidation machinery 57 . However, shortchain FAs, such as butyrate, do not require the acyl carnitine transferase mechanism 58, 59 . β-oxidation involves the actions of multiple chain length-specific enzymes that catalyze the cyclic release of acetyl CoA. These reactions not only promote ATP production via acetyl CoA production, but also by the direct generation of the reducing equivalents FADH 2 and NADH, the electrons of which are then passed to the Q cycle by electron transfer flavoprotein oxidoreductase and to complex I, respectively [60] [61] [62] . In permeabilized cells, measurements of fat oxidation may be obtained by providing carnitine-conjugated FAs.
Medium
In this protocol, we outline the use of octanoylcarnitine (medium-chain acylcarnitine; C8) and palmitoylcarnitine (longchain acylcarnitine; C16). Although unconjugated octanoate has been used to assess respiratory activity, notable uncoupling may occur 63 . Hence, this protocol only applies to the measurement of respiration in permeabilized cells in the presence of acylcarnitines. In addition to the acylcarnitines, 'sparker' malate is added, as this has been shown to increase mitochondrial β-oxidation 64, 65 . This malate-induced increase in β-oxidation activity is likely due to an increased ability to derive NADH from TCA cycle reactions.
Glutamine-supported respiration. Glutamine is the most abundant amino acid in the body, and it has an important role in bioenergetics and biosynthesis. 'Glutamine anaplerosis,' as it has been recently termed 66, 67 , is initiated by glutaminase, which generates glutamate. Glutamate is then catabolized to 2-oxoglutarate (α-ketoglutarate) by glutamate dehydrogenase or transaminases. Glutamine-derived 2-oxoglutarate helps in maintaining TCA cycle intermediates, is critical for the production of building blocks such as nucleotides, lipids and amino acids 68 and is an important source of energy for proliferating cells-especially cancer cells 66, 69, 70 . In permeabilized cell assays, the addition of glutamine and potentially other anaplerotic pathway precursors 71 (e.g., branched-chain amino acids) could be used to identify the differences in anaplerosis-derived energy production. As with glutamate-supported respiration and FA oxidation (vide supra), malate is typically added to enhance glutamine-mediated respiration. Changes in glutamine-supported respiration may indicate alterations in the transamination machinery or complex I-mediated respiration.
Key indices and rate-limiting steps of mitochondrial function.
The order of agents used in classical oxygen electrode experiments, initially shown by Chance and Williamss 1,2 , allows for the understanding of several respiratory states. These mitochondrial states may also be examined in permeabilized cells by using XF technology. Conventionally, oxygen consumption is measured in isolated mitochondria alone in the presence of only P i (state 1). Substrates such as pyruvate + malate or succinate are then added to measure ADP-independent respiratory activity (state 2), which is generally ascribed to proton leak. ADP, once added in the presence of respiratory substrates, results in rapid oxygen consumption and the formation of ATP (state 3), and once all of the ADP is depleted respiration typically returns to rates similar to those of state 2 (state 4). Of these indices, state 3 and state 2 or 4 respiration are most important and allow for the calculation of the respiratory control ratio (RCR) for assessing mitochondrial coupling 9 . This protocol modifies the order of measurement of the respiratory states, first measuring state 3 respiration, and then state 4 o respiration, which is induced by the addition of oligomycin, an inhibitor of ATP synthase (complex V). Importantly, inhibitors may also be used to identify key steps important to the overall rate of respiration. For example, the inhibition of the pyruvate or succinate transporter can be used to investigate substrate transport across the membrane; specific dehydrogenases may be examined by using enzymespecific inhibitors (e.g., malonate for SDH); adenine nucleotide transport may be inhibited with atractylate; and estimations of proton leak may be assessed by the oligomycin-independent rate of oxygen consumption 7, 37, 56 . Collectively, the integration of each of these factors-complex I-derived respiration; complex II-mediated respiration; duroquinol-supported oxygen consumption; complex IV activity; FA oxidation; glutamine oxidation; and the use of inhibitors-allows for a comprehensive assessment of respiratory function in permeabilized cells, which, by deduction, can be used to identify key and site-specific differences in mitochondrial activity between cell types, phenotypes or treatments.
Comparison with other methods
This protocol bridges the gap between measurements of respiration in isolated mitochondria and intact cells 9 . As mentioned above, the XF-permeabilized cell protocol uses far less biological material for examining mitochondrial function than traditional isolated mitochondria assays, it prevents damage and alterations in mitochondrial morphology due to isolation, it prevents mitochondrial subpopulation selection bias and it shows a remarkable increase in throughput, allowing up to 24 or 96 samples to be measured simultaneously (depending on the XF analyzer model). Compared with other permeabilized cell protocols 40, 41 , this method uses 12-to 100-fold fewer cells per sample. In addition, experiments may be designed such that intact cell measurements and permeabilized cell measurements are obtained concurrently. This is notable because it would allow for a clear assessment of the biological significance of differences in mitochondrial energetic parameters on intact cell bioenergetics.
Other high-throughput methods, which rely on Pt-porphyrinbased O 2 -sensing probes in a plate reader format, have been described for the measurement of intact and permeabilized cell mitochondrial function 72, 73 . Such assays have the advantage of flexibility with respect to the use of common microtiter plates, allowing for measurement of up to 384 samples 72, 74 ; however, this methodology is limited in that mineral oil must overlay each sample to limit oxygen diffusion, which makes the addition of chemicals or compounds and subsequent repeated measures on the same samples difficult. With XF technology, a semi-sealed chamber that limits oxygen diffusion is made intermittently 26, 75 , which allows for the accurate measurement of oxygen consumption and provides the user with the ability to inject compounds of interest during the sample assay. Moreover, this technology is becoming more ubiquitous, with more than 600 papers published using XF methodology to date (on the basis of a PubMed database search). Previous protocols for examining mitochondrial function in permeabilized cells have relied primarily on two permeabilizing agents: SAP and DIG 38, 40, 41, 43 ; however, it is possible that mitochondria in some cells will be damaged by these compounds 37 . This protocol also includes the use of mutant rPFO (XF-PMP reagent, Seahorse Biosciences) 37 . PFO is a cholesterol-dependent cytolysin secreted by Clostridium perfringins, and it forms pores in the plasma membrane, which allow the passage of solutes and proteins up to 200 kDa in size [76] [77] [78] [79] . rPFO appears to have a much broader window for use in permeabilized cell experiments compared with reagents such as SAP and DIG 37 . Data suggest that PFO facilitates pore formation by a cholesterol-dependent mechanism, in which its binding to membranes occurs when cholesterol concentration exceeds a certain threshold [80] [81] [82] . Intracellular organelles probably do not possess enough cholesterol to facilitate pore formation by rPFO, and, for this reason, rPFO seems to have a much broader window for use in permeabilized cell experiments compared with reagents such as SAP and DIG. Nevertheless, this protocol demonstrates how to define useful ranges for these more cost-effective permeabilizing reagents.
Limitations
Although XF-permeabilized cell respirometry has several advantages over other methods, limitations remain. Respirometry using an oxygen electrode generally requires relatively small amounts of ADP to promote transient state 3 respiration; hence, once ADP is depleted, state 4 respiration ensues. This allows for the determination of 'the number of moles of ADP phosphorylated to ATP per 2e − flowing through a defined segment of an electron transfer to oxygen,' i.e., the ADP/oxygen (ADP/O) or phosphate/oxygen (P/O) ratio 56 . However, in this XF protocol, high concentrations of ADP (1-4 mM) should be present upon permeabilization, and ADP is not depleted; therefore, the P/O ratio cannot be calculated. However, if need be, one can estimate the P/O ratio by using lower concentrations of ADP Steps 1-8
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Step 31 (e.g., 0.25 or 0.5 mM, similar to that shown by Rogers et al. 83 ). Another rather obvious limitation is accessibility to the XF analyzer. Although not as plentiful as microplate readers, there are now numerous laboratories in multiple countries that use this instrument routinely, as evinced by the growing number of XF publications. In addition, there are currently 25 core research facilities with XF capabilities (http://www.seahorsebio. com/learning/core-facilities.php), which could be called upon to help perform experiments if the investigator does not have access to the equipment. Figure 2 shows a general time frame for permeabilized cell assays. Before examining mitochondrial function in a number of samples by XF analysis or doing comprehensive analyses, it is important to first determine the optimal seeding density for mitochondrial function assays. As shown in Figure 3a , cells may be seeded at a density of 10,000-100,000 cells per well, and oxygen consumption in permeabilized cells can be measured. For the XF 96, the following densities were shown to be optimal: C 2 C 12 myoblasts, 1.5 × 10 4 
Experimental design Optimal cell density. The workflow in

Box 1 | Assessment of cytochrome c release caused by permeabilizing agents • tIMInG 48 h
To prevent the damage of the outer mitochondria membrane, it is important to optimize permeabilizer concentrations. In addition to functional assays shown in Figure 4 , damage to the outer mitochondria membrane may be assessed by measuring the loss of cytochrome c from the mitochondria by western blotting. For this, cells are exposed to the permeabilizing agents at several concentrations, and then cytochrome c, in addition to cytosolic protein markers, is examined (Fig. 5) .
The following outline is a step-by-step protocol (modified from refs. 37,88) to assess mitochondrial integrity by western blotting after exposure to the permeabilizing agent. Choice of permeabilizer. An example of data derived from this initial experiment is shown in Figure 3b , where rat aortic smooth muscle cells (RASMCs) were seeded at various densities and the OCR was measured before permeabilization and after the addition of permeabilizing agent and mitochondrial substrate. As shown by the OCRs after antimycin A and rotenone injection (e.g., Fig. 3b) , non-mitochondrial OCR is very low, as cytosolic oxidases are lost (diluted) upon permeabilization. We 36 and others 38, 40 have found that 25 µg ml −1 SAP or 25 µg ml −1 DIG are good initial concentrations to use for permeabilized cell experiments. As shown in Figure 3c ,d, the data can be plotted to identify how cell seeding density may affect state 3, state 4 o and the RCR. Next, it is essential to ensure that the permeabilizer is optimal. Recent studies have shown that permeabilizers such as DIG have a narrow effective concentration and may cause cytochrome c release from mitochondria, whereas rPFO is not injurious to mitochondria, even at concentrations that are ten times the dose required to permeabilize cells 37 . However, multiple other studies have effectively used reagents such as SAP and DIG to measure bioenergetics in permeabilized cells 38, 40, 41, 43 . To determine which permeabilizer may be best for the experimental conditions and cell types, initial dose-response studies performed with SAP, DIG and/or rPFO can be used to identify optimal concentrations and to assess whether the permeabilizers damage mitochondria within the time frame of a typical XF assay. Concentration-dependent responses of the permeabilizers may be performed after the protocol, in the presence of a substrate such as succinate (+rotenone). An example of this is shown in Figure 4 . Once the optimal concentration of the permeabilizer is determined, assessment of mitochondrial damage, e.g., by measuring cytochrome c release (Fig. 5) , may also be performed (Box 1). However, adding back cytochrome c, e.g., by injecting it via one of the ports as shown in Divakaruni et al. 37 , can be used to provide a quick answer.
Experimental matrices. After identifying the optimal cell density and choosing a permeabilizer, the cells may then be subjected to comprehensive mitochondrial analysis. It is commonly helpful to design experimental matrices to address the following: (i) respiratory complex activity, (ii) glutamine oxidation and (iii) FA oxidation. Of course, the layout of the experiment will Box 1 | (continued) 5 . Gently rinse each well of the confluent six-well plates once with 2 ml of warmed MAS-BSA buffer and then aspirate. 6. Add the various detergent concentrations made in step 4 above into the designated wells, and then incubate the plates in the 37 °C incubator for 25 min. This duration of incubation should correspond to the length of time for which the cells will be exposed to the permeabilizer during the XF assay. 7. Aspirate the MAS-BSA-detergent solution and gently rinse twice with RT PBS. 8. Add 100 µl of protein lysis buffer into each well and proceed to the next step for protein estimation (for XF wells, add 20 µl of lysis buffer).  pause poInt Plates can be stored at -80 °C for later use. 9. Scrape cells from each well and transfer the contents into 1.7-ml Eppendorf tubes. 10. Centrifuge the samples at 4 °C for 10 min at 14,000g by using a bench-top centrifuge. 11. Transfer the supernatants into new, clearly labeled tubes. 12. Use an aliquot (usually 5 µl) of each crude cell protein preparation to estimate the protein concentration. This can be done by using a standard method such as that shown in Box 2. Note: if you are using XF24 plates, use the entire 20 µl for SDS-PAGE. 13 . Pipette between 5 and 20 µg of each crude cell protein preparation into appropriately labeled Eppendorf tubes. 14. Make 2× concentrated gel electrophoresis sample (Laemmli) buffer (see Reagent Setup) containing ~100 mM DTT. 15. Add Laemmli sample buffer into the crude cell protein preparations to yield a final concentration of 1× sample buffer and ~50 mM DTT. The maximum volume of the resulting mixture should not exceed 40 µl. 16. Boil the mixture on a heating block for 5 min at 100 °C. 17. After allowing the samples to cool, pipette them into each lane of a 10.5-14% polyacrylamide gel and electrophorese. 18. Follow a standardized western blotting protocol (e.g., http://www.cellsignal.com/support/protocols/Western_BSA.html) and then blot for the indicated proteins. Table 1 . In addition, intact cell respiratory measurements and permeabilized cell measurements can be combined on the same plate. An experimental template that we commonly use to plan and design experiments is available in Supplementary  Figure 1 . This experimental matrix could, of course, be expanded for use with an XF96 system, in which multiple complexes and treatment groups could be examined.
Controls and replicates.
It is important to note that experimental control groups are helpful for determining whether the experiment worked and for assessing assay-to-assay variability. For example, when you are using the XF permeabilized cell assay to measure FA or glutamine oxidation, it is helpful to include substrates known to give a robust response, e.g., succinate or pyruvate and malate, in two or three wells. This allows the user to determine whether the cells respond to substrates as predicted, and it facilitates comparison between experiments. In addition, exclusion of substrates in one or a few wells is useful as a 'negative' control and helps establish a This can be adjusted depending on the well-to-well intra-assay variability; the % coefficient of variation should be <20%. It is strongly recommended that each experiment be repeated at least three separate times and that the investigator does not rely on one experiment with technical replicates to draw definitive conclusions. Finally, it is helpful to make up all storable reagent stock solutions the day before the assay ( Table 2) . • Adjust the pH to 7.0 with NaOH. This buffer may be stored at room temperature (RT, 25 °C). It is advised to make fresh lysis buffer every 6 months. Gel electrophoresis sample buffer Make 5× concentrated Laemmli buffer (in distilled, deionized H 2 O) containing 400 mM Tris-HCl, 50% (vol/vol) glycerol, 0.1% (wt/vol) bromophenol blue and 10% (wt/vol) SDS; adjust the pH to 6.8 with HCl. The buffer may be stored at RT. It is advised to make fresh Laemmli buffer every 6 months. Table 2 . Respiratory substrates and inhibitors may be stored as aliquots at -20 °C for 2 months. Duroquinol, however, should be made up freshly every 1-2 weeks.
Respiratory substrates and inhibitors See
•
proceDure seeding the cells in the XF cell microplate • tIMInG 6-17 h  crItIcal First, the optimal seeding density must be determined. For this, seed 10-100 × 10 3 cells per well, using, for example, the template shown in Figure 3a . Typically, between 20,000 and 60,000 cells per well are found to be optimal, but this will depend on the cell type.
1|
Grow the cells in a T75 culture dish to achieve the desired amount of cells. ! cautIon Use sterile techniques throughout Steps 1-3.
2|
Before trypsinization, rinse the cells once with 10 ml of sterile PBS (pH 7.4, kept at RT).
3| Add 2-5 ml of trypsin-EDTA solution to the flask and swirl it to make sure that the cells are covered with trypsin solution. Place the flask in the incubator (5% CO 2 ) for 3 min at 37 °C.
4| Add 8 ml of cell culture growth medium to the cell mixture (warmed to 37 °C in the water bath).
5|
Transfer the cell suspension to a 15-ml conical tube and centrifuge it at 300-500g for 5 min at RT.
6|
Aspirate the supernatant and resuspend the cells in 1-3 ml of cell culture growth medium.
7|
Count the cells with a hemocytometer and adjust the concentration of counted cells to ten times the desired cell number to be seeded in each well. For example, if you are seeding 40,000 cells per well, adjust the concentration to 4 × 10 5 cells per ml of culture medium. Prepare enough volume at this cell concentration to seed the entire plate (or the desired number of wells).
8|
Seed the cells into the XF24 culture plate by pipetting 100 µl of the cell suspension into each well. Leave unseeded the four wells indicated with an 'X' in Figure 3a . These wells serve as temperature control and background wells. After the cells attach, which generally takes ~4 h, add 250 µl of growth medium to each well.  crItIcal step The seeding density must be accurately determined for each cell type. Generally, the goal is to have a monolayer of cells that achieves 75-95% confluency at the time of assay. Higher-density seeding could lead to extremely high oxygen consumption, which may obfuscate rate determinations, or it may create a semihypoxic environment. In addition, seeding a homogenous layer of cells is crucial for achieving optimal OCRs with low variability. Orient the pipette as shown in Figure 7 and disperse the cells quickly into the well. The direct application of cells to the bottom of the wells, e.g., as shown in Figure 7b , commonly causes them to cluster in the middle or around the sides. After seeding all the wells, incubate the cells for ~5 min and then examine them by using a light microscope (×10 magnification). If the cells are not evenly distributed, rock or tap the plate gently to redistribute the cells or seed another plate.
synchronizing cells (optional)
• tIMInG 16-24 h 9| (This step is optional, depending on the experiment.) On the next day, carefully aspirate each well and replace the medium with prewarmed DMEM (containing 0-0.5% (vol/vol) FBS and 1% (vol/vol) penicillin-streptomycin) and incubate the plate for 24 h to synchronize the cell cycle of dividing cells. The concentrations of FBS or other growth factors required to synchronize the cells will depend on the cell type.
rehydrating an XF24 Fluxpak • tIMInG 3 h 10| XF FluxPaks comprise a cartridge and a utility plate. At least 3 h before the assay, hydrate the cartridge by adding ~1 ml of XF calibrant solution into each well of the utility plate. Place the cartridge back onto the utility microplate. Typically, it is useful to hydrate a cartridge the night before an experiment.
11|
Incubate the plate in a non-CO 2 incubator at 37 °C.  crItIcal step This hydration step is required for proper functioning of the sensors at the time of OCR measurements. Cartridges may be used within 3-4 h of hydration, but they can be used up to 72 h after the addition of calibrant solution.
Note that the incubator must be humidified if you are hydrating for longer periods of time to prevent the evaporation of calibrant solution. 
14|
Set up an experimental protocol in the XF analyzer according to the manufacturer's instructions. A typical XF running protocol for the permeabilized cell assay is shown in Figure 8 .
15| Pipette ~15 ml of the warmed MAS-BSA solution into a clean conical tube, and use it to make 10× stock concentrations of the compounds to be loaded into the ports of the reagent delivery cartridges ( 38 have found that the FCCP response after permeabilization is markedly improved when FCCP is added simultaneously with both permeabilization agent and substrates compared with the FCCP being added later in the assay. By using this method, we find that the FCCP-stimulated rate is ~20% higher than state 3 respiration in smooth muscle cells; however, this is likely to differ between cell types.
17|
Insert the hydrated XF cartridge into the XF analyzer and hit 'start' to run the calibration step. This should take between 6 and 30 min, depending on your administration settings. ! cautIon Remember to take off the clear cartridge lid before inserting the cartridge into the XF24 analyzer. Also, ensure that the orientation of the cartridge is correct.
replacing the medium with Mas-Bsa buffer • tIMInG 5-10 min 18| Approximately 5-10 min before the end of the calibration protocol, remove the XF culture plate from the incubator and gently aspirate all but 50 µl of DMEM culture medium.
19|
Gently add 700 µl of warmed MAS-BSA buffer to each well.
20|
Aspirate all but 50 µl of the buffer from each well.
21|
Add 625 µl of MAS-BSA buffer to each well (for a total of ~675 µl per well).
22|
Place the cells in a non-CO 2 incubator until the calibration is complete.  crItIcal step All medium aspirations and additions should be performed with the pipette tip placed on the side wall of the well (Fig. 7c,d , respectively). This will prevent the cells from dislodging during these steps. analyzer. 'Mix' and 'wait' periods can be changed as desired. However, it is advisable to keep the 'measure' periods to 2-3 min. Two minutes is typically the minimum time required to generate a rate. Figure 9 . Permeabilized cells not provided with substrate may be used as controls and as measures of state 1 respiration (which should be at or near the non-mitochondrial rate). Calculate these values as follows, by using the points indicated on ? trouBlesHootInG Troubleshooting advice can be found in table 3. (continued) Damage to mitochondria by SAP or DIG, which may be monitored by the loss of cytochrome c or diminishment in state 3 respiration, is usually evident only at concentrations of >25 µg ml −1 SAP or DIG (e.g., Box 1). Examples of the effects of SAP and DIG concentration on mitochondrial activity in smooth muscle cells is shown in Figure 4 . As the cholesterol content of the cell membrane varies with cell types, preliminary experiments, such as that shown in Figure 4 , are advised to identify the appropriate concentration of permeabilizing agent. For rPFO, concentrations from 1 to 10 nM have been shown to be adequate, with 1-3 nM suitable in most cell types 37 . In smooth muscle cells, we find similar state 3 and state 4 o rates with SAP when compared with rPFO (supplementary Fig. 3 ).
Interrogation of mitochondrial function
As mentioned in the INTRODUCTION, this protocol is useful for evaluating complex I-and complex II-mediated respiratory activity, as well as complex III and complex IV integrity. As shown in Figure 10 , measuring each of these indices of mitochondrial function could be expected to yield important information on the ETC. Oxygen consumption in the presence of substrate and ADP (i.e., state 3 respiration) can be expected to increase progressively as electron donation moves upstream in the respiratory chain (Fig. 10a,b) . Respiratory activity in the presence of oligomycin (i.e., state 4 o ) increases more so, such that electron input at complex I yields the highest RCR and electron input at cytochrome c yields the lowest RCR (Fig. 10c) . In Figure 10d -f, we show typical OCR traces and indices of mitochondrial function when octanoyl-l-carnitine, palmitoyl-l-carnitine and glutamine are provided as substrates. Note that the decrease in RCR as electron input moves up the chain can be explained by basic principles. The chemiosmotic theory 5 predicts that the rate of flow of electrons is a function of the respiratory intermediates and the proton motive force (∆p) across the inner mitochondrial membrane. The higher OCRs when duroquinol or TMPD/ascorbate are given can thus be explained by the relatively lower ∆p, as the NADH/O reaction translocates 10H + /2e − and succinate reactions translocate 6H + /2e − , whereas duroquinol and TMPD reactions have lower H + /2e − stoichiometries 56 .
Caution should be used with regard to the use of RCR as a primary metric of mitochondrial coupling in permeabilized cells. For example, as shown in Figure 4d , the RCR of cells permeabilized with 100 µg ml −1 DIG is similar to that of 25 µg ml −1 ; however, it is apparent that the state 3 rate is diminished by the higher concentration of DIG, indicating a marked amount of mitochondrial damage. Therefore, states 3 and 4 should be the primary indices for assessing mitochondrial function in permeabilized cells. The RCR may be used as an additional measure of coupling, especially in experiments in which a given cell type is permeabilized in an identical manner and the effect of a treatment or toxin is assessed.
Practically, these assessments can be used to identify the critical sites of damage or where differences in electron transport may lie. For example, should a similar percentage decrease in OCR be identified with each substrate given (i.e., those donating e − to complexes I (e.g., pyruvate), II (succinate), III (duroquinol) and IV (TMPD)) compared with a control group, then it could be surmised that the defect lies in the latter portions of the respiratory chain (cytochrome c/cytochrome oxidase). The changes in complex II-mediated respiration alone would suggest differences in this input into the Q cycle. Respirasome assemblies are increasingly recognized to be important regulators of mitochondrial 
